Gynecomastia Procedures Global Market Report 2025

The gynecomastia procedures market size has grown strongly in recent years. It will grow from $1.04 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 8%. The growth during the historic period can be attributed to the growing acceptance of male cosmetic surgery, the increasing influence of social media on body image, a rise in the number of plastic surgeons and cosmetic clinics, heightened demand for minimally invasive procedures, and the expansion of medical tourism for cosmetic treatments.

The gynecomastia procedures market size is expected to see strong growth in the next few years. It will grow to $1.51 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to a heightened focus on physical appearance among men, increasing demand for outpatient cosmetic procedures, rising popularity of combination treatment approaches, improved access to financing options for surgeries, and growing investments in cosmetic surgery research and development. Key trends expected during the forecast period include advancements in minimally invasive surgical techniques, innovations in liposuction technology, enhanced anesthesia and recovery protocols, integration of AI in preoperative planning, and progress in scar-reduction and skin-tightening techniques.

The rising prevalence of obesity is expected to drive the growth of the gynecomastia procedures market in the coming years. Obesity is a medical condition marked by excessive accumulation of body fat, typically identified by a body mass index (BMI) of 30 or above, and is associated with numerous health complications. The increase in obesity rates is largely due to increasingly sedentary lifestyles, where limited physical activity and prolonged periods of sitting contribute to weight gain and poor metabolic health. Gynecomastia procedures are used to treat the enlargement of male breast tissue, a condition often worsened by obesity, as excess fat in the chest area can mimic or intensify the appearance of gynecomastia, making surgical intervention a practical solution. For example, in March 2023, the World Heart Foundation, a Switzerland-based non-governmental organization, reported that approximately 2.3 billion adults and children worldwide are overweight or obese, and this number is projected to rise to 2.7 billion by 2025 if current trends continue. Thus, the growing prevalence of obesity is contributing to the expansion of the gynecomastia procedures market.

Leading companies in the gynecomastia procedures market are emphasizing advanced innovations such as non-invasive treatments to minimize surgical risks, enhance patient outcomes, and meet the growing need for safer, more effective therapeutic options. A non-invasive treatment refers to a method that eliminates the need for surgery by utilizing oral medications or external therapies to treat conditions like gynecomastia without incisions or anesthesia. For example, in June 2024, BioZen Limited, a biotechnology company based in the UK, launched an innovative daily pill regimen aimed at treating gynecomastia. This proprietary dual-therapy formulation combines a low dose of tamoxifen (TAM) with indole-3-carbinol (I3C), a naturally occurring compound found in cruciferous vegetables, and is administered as a convenient once-daily oral medication. According to BioZen’s preclinical data, this dual-approach therapy may effectively reverse the hormonal imbalance responsible for gynecomastia, offering a potentially safe, effective, and scalable non-surgical alternative.

In July 2024, Optical Express, a healthcare company based in the UK, acquired Harley Medical Group for an undisclosed sum. Through this acquisition, Optical Express intends to broaden its multidisciplinary healthcare services by incorporating cosmetic and dermatological treatments into its established eye care network across various locations in the UK and Europe. The Harley Medical Group, also based in the UK, is a cosmetic surgery provider known for specializing in procedures such as gynecomastia surgery.

Major players in the gynecomastia procedures market are Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Limited, Spire Healthcare Group plc, InMode Ltd., Lumenis Ltd., Cynosure LLC, Max Healthcare Institute Limited, Alma Lasers Ltd., Pristyn Care Private Limited, Sterling Addlife India Limited, Cutera Inc., Solta Medical Inc., Erchonia Corporation, MicroAire Surgical Instruments LLC, Allure Medspa, Florida Plastic Surgery Group P.A., BioZen Healthcare, Dermawear, The Aesthetica, and Austin Gynecomastia Center.

North America was the largest region in the gynecomastia procedures market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gynecomastia procedure report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gynecomastia procedure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Gynecomastia procedures are medical interventions aimed at reducing the enlargement of male breast tissue, typically resulting from hormonal imbalances. These procedures seek to restore a more masculine chest contour, relieve physical discomfort, and enhance the psychological well-being of individuals experiencing this condition.

The primary types of gynecomastia procedures include liposuction, mastectomy, thyroid hormone therapy, medications, and ultrasound. Liposuction is a cosmetic surgical technique that removes excess fat from targeted areas of the body through suction, helping to reshape and contour the body. The key age groups affected are adolescents, adults, and the elderly, while the main end-users include hospitals, cosmetic surgery centers, and other healthcare facilities.

The gynecomastia procedures market research report is one of a series of new reports that provides gynecomastia procedures market statistics, including the gynecomastia procedures industry global market size, regional shares, competitors with the gynecomastia procedures market share, detailed gynecomastia procedures market segments, market trends, and opportunities, and any further data you may need to thrive in the gynecomastia procedures industry. This gynecomastia procedures market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gynecomastia procedure market consists of revenues earned by entities by providing services such as laser therapy, minimally invasive procedures, post-operative care and follow-up services, and consultation and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.